Patent details

EP1660057 Title: COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS

Basic Information

Publication number:
EP1660057
PCT Application Number:
PCT/US/2004/027612
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047821665
PCT Publication Number:
WO/2005/020972
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
French Title of Invention:
POLYTHERAPIE POUR LE TRAITEMENT DE TROUBLES NEOVASCULAIRES OCULAIRES
German Title of Invention:
KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON OKULAREN NEOVASKULÄREN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
26/08/2004
Grant date:
23/05/2012
EP Publication Date:
23/05/2012
PCT Publication Date:
10/03/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/05/2006
EP B1 Publication Date:
23/05/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/08/2018
Expiration date:
26/08/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/08/2004
 
 

Name:
Ophthotech Corporation
Address:
5 Vaughn Drive Suite 106, Princeton, NJ 08540, United States (US)

Inventor

1

Name:
ADAMIS Anthony, P.
Address:
United States (US)

2

Name:
SHIMA David
Address:
United Kingdom (GB)

3

Name:
CALIAS Perry
Address:
United States (US)

Priority

1

Priority Number:
498407 P
Priority Date:
27/08/2003
Priority Country:
United States (US)

2

Priority Number:
556837 P
Priority Date:
26/03/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/08/2017
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
31/12/2018 Outgoing Correspondence 1